Cellular Therapy showing great success in boosting Oocyte production and increasing success rates of IVF. As a fertility enhancement process is aimed at promoting the formation of natural Oocytes within the ovary.

These MSC release secretions of paracrine growth factors and cytokines such as VEGF, IL-8, and angiopoietin, which act by binding to a multitude of receptors that span the cell membrane in the ovaries. High levels of these factors are secreted from the  cells, facilitating the beneficial effects of these cells. Furthermore, these factors attach to receptors including the VEGF receptor VEGF-R2 and the Angiopoietin receptor Tie-2, both expressed upon a substantial percentage of progenitor cells, further enhancing tissue function and effectiveness.

Our patients who have undergone our MSC cell therapy have shown significant improvement in a relatively short period of time. Depending on the stage of each patient’s condition, our approach has produced results either almost immediately, or within the first few months following treatment. For even the most challenging cases, we have produced improvement within six months of initial treatment.

All MSCs are grown in the SC21 laboratories under strict international guidelines. The MSC are grown with a focus on maintaining their juvenile regenerative qualities.